OTC:CASIF | Free Cash Flow | CASI Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$20.75M$16,000.00-$20.77M
2024-12-31-$29.22M$223,000.00-$29.45M
2023-12-31-$19.97M$204,000.00-$20.17M
2022-12-31-$21.09M$5.61M-$26.7M
2021-12-31-$26.84M$8.95M-$35.79M
2020-12-31-$25.89M$1.5M-$27.39M